<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We analysed the clinical features, course and response to immunosuppressive therapy in 30 patients with <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> associated with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>18 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> developed <z:hpo ids='HP_0011009'>acute</z:hpo> systemic <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Common manifestations were skin <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (n = 15) and <z:hpo ids='HP_0001369'>arthritis</z:hpo> (n = 11) </plain></SENT>
<SENT sid="3" pm="."><plain>Seven patients had an <z:hpo ids='HP_0011009'>acute</z:hpo> clinical syndrome of vasculitic <z:hpo ids='HP_0000988'>skin rash</z:hpo>, <z:hpo ids='HP_0001945'>fever</z:hpo> and <z:hpo ids='HP_0001369'>arthritis</z:hpo> with peripheral <z:hpo ids='HP_0000969'>oedema</z:hpo> in three and <z:hpo ids='HP_0002113'>pulmonary infiltrates</z:hpo> in five of these seven patients </plain></SENT>
<SENT sid="4" pm="."><plain>Other <z:hpo ids='HP_0011009'>acute</z:hpo> manifestations included <z:hpo ids='HP_0001701'>pericarditis</z:hpo>, <z:hpo ids='HP_0002202'>pleural effusions</z:hpo>, <z:mp ids='MP_0001209'>skin ulceration</z:mp>, <z:hpo ids='HP_0001250'>seizures</z:hpo>, <z:hpo ids='HP_0100614'>myositis</z:hpo> and <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> or isolated autoimmune manifestations (n = 11) included <z:hpo ids='HP_0000099'>glomerulonephritis</z:hpo>, <z:hpo ids='HP_0001271'>polyneuropathy</z:hpo>, <z:hpo ids='HP_0000999'>pyoderma</z:hpo> gangrenosum, <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and <z:e sem="disease" ids="C0162323" disease_type="Disease or Syndrome" abbrv="">polyarthritis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Classic <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorders</z:e> recognized included <z:e sem="disease" ids="C0032453" disease_type="Disease or Syndrome" abbrv="">relapsing polychondritis</z:e>, <z:e sem="disease" ids="C0032533" disease_type="Disease or Syndrome" abbrv="pmr">polymyalgia rheumatica</z:e>, <z:e sem="disease" ids="C0034734" disease_type="Disease or Syndrome" abbrv="">Raynaud's syndrome</z:e> and <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sj√∂gren's syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Autoimmune manifestations responded to immunosuppressive therapy (primarily <z:chebi fb="0" ids="8382">prednisone</z:chebi>) in 26/27 patients treated </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, cytopenias improved substantially in six patients, including complete normalization of peripheral blood counts in two patients with cytogenetic remission in one </plain></SENT>
<SENT sid="9" pm="."><plain>Patients with a haematological response to immunosuppressive therapy had improved survival compared with non-responding patients </plain></SENT>
<SENT sid="10" pm="."><plain>The autoimmune syndrome was implicated as a primary cause of <z:hpo ids='HP_0011420'>death</z:hpo> in 8/17 patients who died </plain></SENT>
<SENT sid="11" pm="."><plain>Autoimmune manifestations may be more common than previously recognized in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Aggressive therapy with <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> in selected patients often controls autoimmune phenomena associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and may lead to haematological responses in some patients </plain></SENT>
</text></document>